Skip to content

Public FDA record

Z-2942-2020: PROFEMUR Neck Extra Long Titanium, Catalog Numbers: PHA01206, PHA01236, PHA01256. Hip prosthesis compone

Recall record Z-2942-2020 for MicroPort Orthopedics Inc.. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-2942-2020
Company in FDA record
MicroPort Orthopedics Inc.
FDA classification date
Sep 18, 2020
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class I

Reason stated in the source

MicroPort Orthopedics Inc. states that there have been reports of fractures of the long and extra-long Titanium modular femoral neck component after implantation. Worldwide there were 680 Long and X-Long PROFEMUR Titanium modular neck fractures among 123,840 global sales representing is a cumulative rate of modular neck device fracture of 0.55% from 2002 to 2019. Within the United States there were 349 Long and X-Long PROFEMUR Titanium modular neck fractures among 15,786 United States sales representing a cumulative rate of modular neck device fracture with a fracture rate in the United States of 2.21% from 2002 to 2019. There is an average time of 5.4 years to device fracture after implantation.

Source facts

Action
The firm initiated the recall by letter on 07/31/2020. The letter provide the following instructions: "Distributors: 1. Please immediately cease use and distribution of these products. 2. Please check your stock, including all consignment stock to immediately determine if you have any affected product. 3. Please complete the form on the last page of this notification and return the form and any affected products to MicroPort Orthopedics per the Actions section of this notification. 4. Please assist us by distributing this notification to all hospitals and surgeons in your territory and collecting and returning completed forms to MicroPort Orthopedics. NOTE: This notice will also be sent directly to the hospitals and surgeons, however they only need to complete the information once, either provided through the distributor or send directly back to MicroPort Orthopedics. Hospitals: 1. Please immediately cease use of these products. 2. Please complete the form on the last page of this notification and return the form and any affected products to MicroPort Orthopedics per the Actions section of this notification. Surgeons: 1. Please immediately cease use of these products. 2. You can continue to monitor your patients per your normal protocol. There are no diagnostic techniques which can predict an unexpected postoperative failure. 3. Should a patient present with sudden pain, instability and difficulty walking/performing common tasks a postoperative fracture can be confirmed via x-ray. 4. Please sign and return this form per the instructions to confirm your notification of this action. ACTIONS: 1. Please complete and return the enclosed form immediately even if you do not have any affected product to return. This information is essential in order to carry out effectiveness checks required per FDA guidelines. Return the completed form by fax to: 901-867-4771, or by e-mail to: PostMarket@ortho.microport.com. Please feel free to
Initiated
2020-07-31
Root cause
Device Design
Terminated
2024-04-16
Distribution
worldwide, except China and Japan
Recall number
Z-2942-2020
Recall status
Terminated
CDRH record ID
182851
FDA classified
2020-09-18
Recall event number
86153

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗